Huntington National Bank’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Hold
1
﹤0.01% 4073
2025
Q4
$2 Hold
1
﹤0.01% 3931
2025
Q3
$3 Sell
1
-349
-100% -$1.2K ﹤0.01% 3930
2025
Q2
$1.32K Buy
350
+83
+31% +$327 ﹤0.01% 2296
2025
Q1
$1.21K Buy
267
+87
+48% +$460 ﹤0.01% 2332
2024
Q4
$1.27K Sell
180
-56
-24% -$446 ﹤0.01% 2344
2024
Q3
$1.92K Sell
236
-29
-11% -$210 ﹤0.01% 2243
2024
Q2
$1.69K Buy
265
+111
+72% +$713 ﹤0.01% 2204
2024
Q1
$1.16K Sell
154
-1
-0.6% -$9 ﹤0.01% 2254
2023
Q4
$1.44K Buy
155
+65
+72% +$531 ﹤0.01% 2144
2023
Q3
$911 Sell
90
-8
-8% -$96 ﹤0.01% 2223
2023
Q2
$1.23K Hold
98
﹤0.01% 2130
2023
Q1
$1.14K Buy
+98
New +$1.25K ﹤0.01% 2010

Other funds holding HCAT

Huntington National Bank's HCAT Position: Q1 2026 in Review

Huntington National Bank held its Health Catalyst (HCAT) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4073.

Huntington National Bank first reported a position in HCAT in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.92K in Q3 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Huntington National Bank held 1 share of Health Catalyst worth $1 as of Q1 2026.
  • Huntington National Bank left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4073 holding.
  • Huntington National Bank first reported a position in Health Catalyst in Q1 2023 and has held it in 13 quarters since.
  • Huntington National Bank's Health Catalyst position peaked at $1.92K in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.